In last trading session, Hoth Therapeutics Inc (NASDAQ:HOTH) saw 6.02 million shares changing hands with its beta currently measuring 0.52. Company’s recent per share price level of $0.98 trading at $0.01 or 0.38% at ring of the bell on the day assigns it a market valuation of $12.89M. That closing price of HOTH’s stock is at a discount of -287.76% from its 52-week high price of $3.80 and is indicating a premium of 40.82% from its 52-week low price of $0.58. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.82 million shares which gives us an average trading volume of 8.92 million if we extend that period to 3-months.

For Hoth Therapeutics Inc (HOTH), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.00. Splitting up the data highlights that, out of 1 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 1 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.

Hoth Therapeutics Inc (NASDAQ:HOTH) trade information

Upright in the green during last session for gaining 0.38%, in the last five days HOTH remained trading in the red while hitting it’s week-highest on Wednesday, 04/02/25 when the stock touched $0.98 price level, adding 6.67% to its value on the day. Hoth Therapeutics Inc’s shares saw a change of 30.78% in year-to-date performance and have moved -4.08% in past 5-day. Hoth Therapeutics Inc (NASDAQ:HOTH) showed a performance of -21.10% in past 30-days. Number of shares sold short was 0.28 million shares which calculate 0.26 days to cover the short interests.

Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 27.96% during past 5 years. In 2025, company’s earnings growth rate is likely to be around 46.59% while estimates for its earnings growth in next 5 years are of 27.65%.

Hoth Therapeutics Inc (NASDAQ:HOTH)’s Major holders

Insiders are in possession of 0.92% of company’s total shares while institution are holding 3.53 percent of that, with stock having share float percentage of 3.57%. Investors also watch the number of corporate investors in a company very closely, which is 3.53% institutions for Hoth Therapeutics Inc that are currently holding shares of the company.